Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the recipient of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 25,178 shares, a decline of 55.7% from the February 12th total of 56,789 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average trading volume of 85,737 shares, the short-interest ratio is presently 0.3 days. Based on an average trading volume of 85,737 shares, the short-interest ratio is presently 0.3 days. Currently, 1.3% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Akanda in a research report on Monday, January 12th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell”.
Check Out Our Latest Research Report on AKAN
Akanda Trading Up 2.7%
Akanda Company Profile
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Featured Stories
- Five stocks we like better than Akanda
- The gold chart Wall Street is terrified of…
- “This AI Giant is About to Go Bust”
- I tried out Elon Musk’s new AI tech — it floored me
- Elon Musk’s $1 Quadrillion AI IPO
- Is Trump Done? Shocking leak…
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
